Analysts name 2 fantastic ASX 200 shares to buy

Here are two ASX 200 shares analysts rate highly…

| More on:
Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is home to a large number of quality companies with the potential to generate strong returns for investors in the future.

Two that analysts are particularly positive on are listed below. Here's why they are tipping them as buys right now:

Breville Group Ltd (ASX: BRG)

The first ASX 200 share to look at is Breville. is one of the world's leading appliance manufacturers. As well as the eponymous Breville brand, it also has the Sage, Kambrook, and Baratza brands.

Breville has been growing at a consistently solid rate for the last decade and looks well-placed to continue this trend over the next decade. This is thanks to the popularity of its brands, its international expansion, acquisitions, favourable consumer trends, and its continued investment in R&D.

Macquarie is very positive on the company's future and expects further strong growth in the coming years. Last week its analysts retained their outperform rating and $34.37 price target on the company's shares. The broker notes that rival DeLonghi and one of Breville's distributors in the US recently reported strong results. It feels this bodes well for Breville's performance.

ResMed Inc. (ASX: RMD)

Another ASX 200 share that could be a top option is ResMed. It is a medical device company with a focus on the sleep treatment market.

Thanks to its industry-leading products, wide distribution network, and successful acquisitions, ResMed has been growing at a very strong rate over the last few years.

The good news is that thanks to its significant market opportunity, the growing prevalence of sleep disorders, and new product launches, it has been tipped to continue doing so for the foreseeable future. In addition, ResMed's near term performance is being boosted by a major product recall from rival Philips.

Morgans is a fan of ResMed. Its analysts currently have an add rating and $40.80 price target on its shares. The broker believes ResMed is well-placed as it builds a unique, patient-centric, connected-care digital platform that addresses the main pinch points across the healthcare value chain.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Growth Shares

Big returns could be coming for high-flying Lovisa shares

Morgans doesn't believe it is too late to snap up this hot stock.

Read more »

Smiling young parents with their daughter dream of success.
Growth Shares

Why these ASX 200 growth shares could be top buys now

Analysts are feeling bullish about these growth stocks. Let’s see what they’re saying.

Read more »

Concept image of a man in a suit with his chest on fire.
Growth Shares

Ignore the noise and buy this hot ASX growth stock

A recent pullback may have created a buying opportunity according to Bell Potter.

Read more »

An ASX investor relaxes on her couch as the Harvey Norman share price drops due to the shares trading ex-dividend from today.
Growth Shares

Fund manager rates these 2 undervalued ASX All Ords shares as buys

A fundie has named two underrated stocks you need to know about.

Read more »

A young well-dressed couple at a luxury resort celebrate successful life choices.
Growth Shares

A once-in-a-decade chance to get rich buying ASX growth stocks?

Analysts think these shares are buys. Could they be the key to growing your wealth?

Read more »

Three exuberant runners dash towards the camera. One raises her arms in triumph; another jumps in the air with arms raised. The third runner gives a satisfied smile.
Growth Shares

3 hypergrowth ASX shares to buy in 2024 and beyond

If you're willing to accept some higher risk, these rapidly expanding companies could be worth a long-term chance.

Read more »

A young female investor with brown curly hair and wearing a yellow top and glasses sits at her desk using her calculator to work out how much her ASX dividend shares will pay this year
Growth Shares

These mid-cap ASX shares could rise 30% to 40%

Goldman Sachs thinks big returns could be on the cards for these mid caps.

Read more »

Woman in celebratory fist move looking at phone
Growth Shares

Broker says these ASX growth shares with very bright futures are top buys

The team at Morgans thinks these are the shares to buy now.

Read more »